Cost–utility analysis of dupilumab compared with endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyps. Evaluation in Colombia, a developing country

References

• Bailey LN, Garcia JAP, Grayson JW. Chronic rhinosinusitis: phenotypes and endotypes. Curr Opin Allergy Clin Immunol. 2021;21(1):24–29.
   PubMed Web of Science ®Google Scholar
• Epperson MV, McCann AC, Phillips KM, et al. Unbiased measure of general quality of life in chronic rhinosinusitis reveals disease modifiers. Laryngoscope. 2021;131(6):1206–1211.
   PubMed Web of Science ®Google Scholar
• Ramaswamy US, Patel VA, Lee SE. Managing chronic rhinosinusitis in severe asthma. Curr Opin Pulm Med. 2021;27(1):23–28.
   PubMed Web of Science ®Google Scholar
• Smith KA, Alt JA. The relationship of chronic rhinosinusitis and depression. Curr Opin Otolaryngol Head Neck Surg. 2020;28(1):1–5.
   PubMed Web of Science ®Google Scholar
• Kuiper JR, Hirsch AG, Bandeen-Roche K, et al. Workplace indirect cost impacts of nasal and sinus symptoms and related conditions. Journal of Occupational & Environmental Medicine. 2019;61(8):e333–9.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya N, Gilani S. Prevalence of potential adult chronic rhinosinusitis symptoms in the United States. Otolaryngol Head Neck Surg. 2018;159(3):522–525.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhou A, Emmanuel B, et al. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Curr Med Res Opin. 2020;36(11):1891–1897.
   Web of Science ®Google Scholar
• Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016;4(4):565–572.
   PubMed Web of Science ®Google Scholar
• Rosati D, Rosato C, Pagliuca G, et al. Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps. Am J Otolaryngol. 2020;41(1):102286.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(1):1–464. .
   Web of Science ®Google Scholar
• Scangas GA, Wu AW, Ting JY, et al. Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Laryngoscope. 2021;131(1):E26–33.
   PubMed Web of Science ®Google Scholar
• Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: a systematic review. Laryngoscope. 2015;125(7):1547–1556.
   PubMed Web of Science ®Google Scholar
• Laidlaw TM, Mullol J, Woessner KM, et al. Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract. 2021;9(3):1133–1141.
   PubMed Web of Science ®Google Scholar
• Yong M, Wu YQ, Howlett J, et al. Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease. Int Forum Allergy Rhinol. 2021;11(12):1626–1636. .
   PubMed Web of Science ®Google Scholar
• Rudmik L, Soler ZM, Mace JC, et al. Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope. 2015;125(1):25–32.
   PubMed Web of Science ®Google Scholar
• Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638–50. 2019.
   PubMed Web of Science ®Google Scholar
• Desrosiers M, Mannent LP, Amin N, et al. Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP. Rhinology. 2021;59(3):301–311.
   PubMed Web of Science ®Google Scholar
• Crump RT, Lai E, Liu G, et al. Establishing utility values for the 22-item Sino-Nasal Outcome Test (SNOT-22) using a crosswalk to the EuroQol-five-dimensional questionnaire-three-level version (EQ-5D-3L). Int Forum Allergy Rhinol. 2017;7(5):480–487.
   PubMedGoogle Scholar
• Remenschneider AK, Scangas G, Meier JC, et al. EQ-5D-derived health utility values in patients undergoing surgery for chronic rhinosinusitis. Laryngoscope. 2015;125(5):1056–1061.
   PubMed Web of Science ®Google Scholar
• Luk LJ, Steele TO, Mace JC, et al. Health utility outcomes in patients undergoing medical management for chronic rhinosinusitis: a prospective multiinstitutional study. Int Forum Allergy Rhinol. 2015;5(11):1018–1027.
   PubMed Web of Science ®Google Scholar
• Delemarre T, Holtappels G, De Ruyck N, et al. Type 2 inflammation in chronic rhinosinusitis without nasal polyps: another relevant endotype. J Allergy Clin Immunol. 2020;146(2):337–43.e6.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu Z. [Function and modulation of type II innate lymphoid cells and their role in chronic upper airway inflammatory diseases]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017;52(2):130–135.
   PubMedGoogle Scholar
• Ramakrishnan VR, Kingdom TT, Nayak JV, et al. Nationwide incidence of major complications in endoscopic sinus surgery. Int Forum Allergy Rhinol. 2012;2(1):34–39.
   PubMed Web of Science ®Google Scholar
• Stankiewicz JA, Lal D, Connor M, et al. Complications in endoscopic sinus surgery for chronic rhinosinusitis: a 25-year experience. Laryngoscope. 2011;121(12):2684–2701.
   PubMed Web of Science ®Google Scholar
• Dalziel K, Stein K, Round A, et al. Endoscopic sinus surgery for the excision of nasal polyps: a systematic review of safety and effectiveness. Am J Rhinol. 2006;20(5):506–519.
   PubMedGoogle Scholar
• Lindstrom DR, Toohill RJ, Loehrl TA, et al. Management of cerebrospinal fluid rhinorrhea: the Medical College of Wisconsin experience. Laryngoscope. 2004;114(6):969–974.
   PubMed Web of Science ®Google Scholar
• Stankiewicz JA, Hotaling J. Medicolegal issues in endoscopic sinus surgery and complications. Otolaryngol Clin North Am. 2015;48(5):827–837.
   PubMed Web of Science ®Google Scholar
• Beck LA, Thaçi D, Deleuran M, et al. Dupilumab provides favorable safety and sustained efficacy for up to 3 years in an open-label study of adults with moderate-to-severe atopic dermatitis. Am J Clin Dermatol. 2020;21(4):567–577.
   PubMed Web of Science ®Google Scholar
• Soler ZM, Wittenberg E, Schlosser RJ, et al. Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope. 2011;121(12):2672–2678.
   PubMed Web of Science ®Google Scholar
• Nemeth B, Vincziczki A. The role of half-cycle correction in the models used for health technology assessment. Value Health. 2013;16:A592–593.
   Google Scholar